Clinical Trial: Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117435) titled 'Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases' on Aug. 05.

Brief Summary: This is a phase Ib/III, randomized, multicenter study evaluating the efficacy and safety of hepatic arterial infusion of paclitaxel cationic liposome in combination with systemic therapy (Oxaliplatin, Capecitabine, with or without Bevacizumab) as first-line treatment in colorectal liver metastases.

Study Start Date: May 13

Study Type: INTERVENTIONAL

Condition: Colorectal Liver Metastases First-line Treatment

Intervention: DRUG: paclitaxel cationic lipos...